Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  View Cart Check Out

Country Report

NRT Smoking Cessation Aids in

NRT Smoking Cessation Aids in the US

Oct 2019

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

NRT smoking cessation aids growth slowing

In 2019, the overall market for NRT smoking cessation aids in the US continued its slowdown over the past five years. With little product innovation coming in 2019, NRT products remain largely unchanged with its three dominating variations, gum, lozenges, and patches, being the most popular.

NRT lozenges capitalising on changing consumer preferences

NRT lozenges remains the fastest growing subcategory in NRT smoking cessation aids in 2019. Compared to patches, both gum and lozenge varieties offer flavours appealing to consumers of all age ranges, furthermore lozenges are more likened to a candy format.

Backlash against e-vapour products provides room for NRT growth

Despite the unprecedented growth of e-vapour products in the US, opponents to e-vapour products concerned with growing access to teenagers are increasing efforts to curb younger demographics’ usage. In 2019, the FDA has revamped its efforts to limit in-store sales of fruit-flavoured e-liquids, and San Francisco has gone as far as banning the sale of all e-vapour products within its city limits.

COMPETITIVE LANDSCAPE

Nicorette from GSK Consumer Healthcare maintaining dominance

Nicorette and Nicoderm CQ’s US licenser GSK Consumer Healthcare continues to maintain the largest share in NRT smoking cessation aids in 2019. While private label brands from some of the US’ largest retail chains, such as Walmart and CVS, have slowly acquired share in NRT smoking cessation aids, GSK’s product lines have dominated brand recognition in the space.

Nicorette launches coated lozenges with celebrity endorsement

In its first major new product launch in 10 years, Nicorette (GSK) has launched a lozenge called the Coated Ice Mint Lozenge. In oral formats of NRT, a major factor affecting consumer opinion is taste.

Files are delivered directly into your account within a few minutes of purchase.

Samples

NRT Smoking Cessation Aids Sample Report NRT Smoking Cessation Aids Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the NRT Smoking Cessation Aids industry in USA with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the NRT Smoking Cessation Aids industry in USA, our research will save you time and money while empowering you to make informed, profitable decisions.

The NRT Smoking Cessation Aids in USA market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Production, imports by origin, exports by destination
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of NRT Smoking Cessation Aids in USA?
What are the major brands in USA?
How have tobacco bans affected the sales of NRT Smoking Cessation Aids?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

NRT Smoking Cessation Aids in the US - Category analysis

HEADLINES

PROSPECTS

NRT smoking cessation aids growth slowing

NRT lozenges capitalising on changing consumer preferences

Backlash against e-vapour products provides room for NRT growth

COMPETITIVE LANDSCAPE

Nicorette from GSK Consumer Healthcare maintaining dominance

Nicorette launches coated lozenges with celebrity endorsement

CATEGORY DATA

Table 1 Sales of NRT Smoking Cessation Aids by Category: Value 2014-2019
Table 2 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2015-2019
Table 4 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2016-2019
Table 5 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
Table 6 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024

Consumer Health in the US - Industry Overview

EXECUTIVE SUMMARY

Consumer demand for naturals stimulates both growth and competition

Preventative health remains a key focus

Key brands in OTC maintain their dominance

New positionings drive growth in vitamins and dietary supplements (VDS)

Continued growth expected over the forecast period, with high variations across categories

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format and Category: % Value 2019
Table 16 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

Megatrends

Country Report

NRT Smoking Cessation Aids in the US

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

NRT smoking cessation aids growth slowing

NRT lozenges capitalising on changing consumer preferences

Backlash against e-vapour products provides room for NRT growth

COMPETITIVE LANDSCAPE

Nicorette from GSK Consumer Healthcare maintaining dominance

Nicorette launches coated lozenges with celebrity endorsement

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

NRT Smoking Cessation Aids in the US - Category analysis

HEADLINES

PROSPECTS

NRT smoking cessation aids growth slowing

NRT lozenges capitalising on changing consumer preferences

Backlash against e-vapour products provides room for NRT growth

COMPETITIVE LANDSCAPE

Nicorette from GSK Consumer Healthcare maintaining dominance

Nicorette launches coated lozenges with celebrity endorsement

CATEGORY DATA

Consumer Health in the US - Industry Overview

EXECUTIVE SUMMARY

Consumer demand for naturals stimulates both growth and competition

Preventative health remains a key focus

Key brands in OTC maintain their dominance

New positionings drive growth in vitamins and dietary supplements (VDS)

Continued growth expected over the forecast period, with high variations across categories

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Recently Viewed

Complete Catalogue

Country Reports